It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out. Before they take the plunge, others get to know the hidden potential and enter into these stocks, pushing them out of reach.
So, instead of repenting, spotting the off-the-radar potential winners and immediately investing in them could be a smart decision.
One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is Genmab A/S (GNMSF - Free Report) . This Medical - Biomedical and Geneticsstock has actually seen estimates significantly rise over the past month for the current fiscal year. But that is not yet reflected in its price, as the stock gained only 2.7% over the same time frame.
GENMAB A/S Price and Consensus
You should not be concerned about the price remaining muted going forward. This year’s expected earnings growth over the prior year is 10.7%, which should ultimately translate into price appreciation.
And if this isn’t enough, GNMSF currently carries a Zacks Rank #2 (Buy) which further underscores the potential for its outperformance (See the performance of Zacks' portfolios and strategies here: About Zacks Performance). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
So if you are looking for a stock flying under-the-radar that is well-equipped to bounce down the road, make sure to consider Genmab. Solid estimate revisions and an impressive Zacks Rank suggest that better days may be ahead for GNMSF and that now might be an interesting buying opportunity.
Zacks’ Best Private Investment Ideas
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.
Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades >>